Penile Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021

Report Code: ZMR-97 | Report Format : | Status : Upcoming |

Abstract

Prostate cancer, testicular cancer, and penile cancer are specific to male related cancers. Prostate cancer is the most prevalent in males with respect to penile cancer. Penile cancer in which cancerous cell form in penis. Penile cancer is commonly associated with HPV (human papiloma virus) & HIV (human immune deficiency virus). Other causes of penile cancer are tobacco, poor hygiene, age & other skin problem. Symptoms includes are lumps, bleeding, redness etc.

According to the U.S National Cancer Institute study show 40% of all penile cancer as a result of HPV infections, whereas HIV patients exhibit eight time increased risk of penile cancer. Hence penile cancer rate is high in developing countries like south Asia, South America and Africa. Penile cancer majorly classify into squamous cell carcinoma, intraepithelial neoplasia, bowenoid papulosis and invasive carcinoma of the penis. Majority of penile cancer patients have exhibited squamous cell carcinoma. Initially penile cancer is diagnosed by physical examination of penis followed by biopsy of outer growth i.e. Wart or skin abscess. Chemotherapy, antiviral therapy and surgical excision are common mode for the treatment of penile cancer.

Penile cancer treatment market is driven by increasing incidence of penile cancer across globe. Furthermore, medicines coupled with advance technology & economical treatments are the major driven factor for increase in penile cancer treatment market. However, lack of awareness, healthcare literacy, and commercially less availability of drugs are major restraining factors that is expected to curb the market growth in the near future. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies, literacy rate are expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the penile cancer treatment market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the penile cancer treatment has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the penile cancer treatment market based on type of disease, therapy, diagnostic test and regional segment. The penile cancer type’s market segment held the largest market share in 2015.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America was the leading segment of penile cancer treatment market followed by Europe in 2015, as in these regions the number of reported cases are high in number, and so is the affordability of drugs.  The penile cancer treatment market is expected to witness the highest growth in the South America & Asia-Pacific region in the coming years due to poor hygiene standards, large number of HIV patient population.

The report covers scenario including the company overviews, financial revenues of the key participants. Key players included in report are  Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Novartis AG, and others.

This report segments the penile cancer treatment market are:-

Penile Cancer Treatment Market: Type Analysis

  • Squamous cell cancer of penis
  • Aden carcinoma of penis
  • Melanoma of the penis
  • Basal cell cancer of penis
  • Sarcoma of penis

Penile Cancer Treatment Market: Type Of Therapy Segment Analysis

  • Radiation Therapy
  • Chemotherapy
  • Biological Therapy
  • Surgery (Cryosurgery, Laser Surgery)

Penile Cancer Treatment Market:  Diagnostic Test Segment Analysis

  • Biopsy
  • Ultrasound
  • Imaging tests

Penile Cancer Treatment Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia pacific
  • Latin America
  • Middle east & Africa

Related Reports

Medical Foam Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1129 | Report Format:

Global Medical Foam Market: Overview Medical graded foam has specific antimicrobial substances present in it in order to reduce the risks of the spread of bacteria, germs, and diseases in the hospitals or other medical sectors by its property of resisting against the contaminants. The medical fo...Read More

Chromatography Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1112 | Report Format:

Global Chromatography Reagents Market: Overview Chromatography is a parting method utilized to separate solutes and components in the moving fluid stream via chromatographic reagents. Chromatography has several applications in chemical and biological fields. Chromatography method and its reagent...Read More

Antinuclear Antibody Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1085 | Report Format:

Global Antinuclear Antibody Test Market: Overview The antinuclear antibodies are autoantibodies that attach to the specific contents of the nucleus present in the cell. They are also known as antinuclear factor or ANF. The autoantibodies are produced in the human body against the foreign particl...Read More

Myocardial Infarction Treatment Market by Product type (Antiplatelet agents, Glycoprotein IIb/IIIa inhibitors, Antithrombotic agents, Beta-adrenergic blockers, Vasodilators, Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin-Receptor blockers, Analgesics, Thrombolytics); Distribution channel (Hospitals, Hospital Pharmacies, Drug Stores and Online Drug Stores); and Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Feb-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-1084 | Report Format:

The report covers forecast and analysis for the myocardial infarction treatment market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the myocardial infarct...Read More

In Vitro Diagnostics (IVD) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1065 | Report Format:

Global In Vitro Diagnostics (IVD) Market: Overview In-vitro diagnostics tests are the tests performed outside the body of a patient. It uses reagents, devices, calibrators, analytical instruments, and systems for examination, detection of diseases, and health condition. Global In Vitro Diagnos...Read More

Choose License Type:
Latest Published Reports

View All Published Reports